Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: Implications for allostatic load

Brain Research

Volumn 953, Issue 1-2, 2002, Pages 82-92

  Tannenbaum, B ^a   Tannenbaum, G S ^b   Sudom, K ^a   Anisman, H ^a  

^a CARLETON UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Allostatic load; Anxiety; Chronic stress; Depression; Interleukin 1 ; Serotonin

Indexed keywords

CORTICOSTERONE; CYTOKINE; INTERLEUKIN 1BETA; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FORCED SWIMMING TEST; GROWTH HORMONE BLOOD LEVEL; ILLNESS BEHAVIOR; IMMUNE RESPONSE; MALE; MOUSE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SOCIAL INTERACTION; STRESS;

ACUTE DISEASE; AGGRESSION; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN; CHRONIC DISEASE; CORTISONE; DEPRESSION; ELECTROSHOCK; GROWTH HORMONE; INTERLEUKIN-1; MALE; MICE; MICE, INBRED STRAINS; NOREPINEPHRINE; ODORS; SEROTONIN; STRESS; SWIMMING;

EID: 0037145731     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03273-0     Document Type: Article

References (69)

1. Anisman H., Merali Z. Anhedonic and anxiogenic effects of cytokine exposure. Adv. Exp. Med. Biol. 461:1999;199-233.
2. Anisman H., Hayley S., Kelly O., Borowski T., Merali Z. Psychogenic, neurogenic and systemic stressor effects on plasma corticosterone and behaviors: mouse strain-dependent outcomes. Behav. Neurosci. 115:2000;443-454.
3. Anisman H., Shanks N., Zalcman S., Zacharko R.M. Multisystem regulation of performance deficits induced by stressors: an animal model of depression. Martin-Iverson M.T., Animal Models in Psychiatry. Vol. II:1991;1-55 Humana Press, Clifton, NJ.
4. Armario A., Garcia-Marquez C., Jolin T. Crowding induced changes in basal and stress levels of thyrotropin and somatotropin in male rats. Behav. Neural Biol. 48:1987;334-343.
5. Bergad P.L., Schwarzenberg S.J., Humbert J.T., Morrison M., Amarasinghe S., Towle H.C., Berry S.A. Inhibition of growth hormone action in models of inflammation. Am. J. Physiol. Cell Physiol. 279:2000;C1906-1917.
6. Biondi M. Effects of stress on immune functions: an overview. Ader R., Felten D.L., Cohen N., Psychoneuroimmunology. Vol. 2:1989;189-226 Academic Press, New York.
7. Blanchard R.J., McKittrick C.R., Blanchard D.C. Animal models of social stress: effects on behavior and brain neurochemical systems. Physiol. Behav. 73:2001;261-271.
8. Bodnoff S.R., Suranyi-Cadotte B.E., Quirion R., Meaney M.J. Role of the central benzodiazepine receptor system in behavioral habituation to novelty. Behav. Neurosci. 103:1989;209-212.
9. Bodnoff S.R., Suranyi-Cadotte B., Quirion R., Meaney M.J. A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology. 97:1989;277-279.
10. Bodnoff S.R., Suranyi-Cadotte B., Aitken D.H., Quirion R., Meaney M.J. The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology. 95:1988;298-302.
11. Bornstein S.R., Webster E.L., Torpy D.J., Richman S.J., Mitsiades N., Igel M., Lewis D.B., Rice K.C., Joost H.G., Tsokos M., Chrousos G.P. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation. Endocrinology. 139:1998;1546-1555.
12. Brebner K., Hayley S., Merali Z., Anisman H. Synergistic effects of interleukin-1, interleukin-6, and TNF-α: neuroendocrine, neurochemical and behavioral changes. Neuropsychopharmacology. 22:2000;566-580.
13. Brindley D.N., Rolland Y. Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis. Clin. Sci. (Lond.). 77:1989;453-461.
14. Britton D.R., Britton K.T. A sensitive open field measure of anxiolytic drug activity. Pharmacol. Biochem. Behav. 15:1981;577-582.
15. Chieuh C.C., Zukowska-Grojec Z., Kirk K.L., Kopin J.L. 6-Fluorocatecholamine as a false adrenergic neurotransmitter. J. Pharmacol. Exp. Ther. 225:1983;529-533.
16. Corsi M.M., Fulgenzi A., Gaja G., Falchi M., Bertelli A.A., Boctelli A.A., Ferrero M.E. Effect of acute and chronic inflammation on plasma growth hormone levels in rats. Drugs Exp. Clin. Res. 23:1997;117-122.
17. Dantzer R., Bluthe R.M., Aubert A., Goodall G., Bret-Dibat J.L., Kent S., Goujon E., Laye S., Parnet P., Kelley K.W. Mechanisms of the behavioral effects of cytokines. Adv. Exp. Med. Biol. 461:1999;83-106.
18. Deutch A.Y., Roth R.H. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Uylings H.B.M., Van Eden C.G., De Bruin J.P.C., Corner M.A., Feenstra M.G.P., Progress in Brain Research. Vol. 85:1990;367-403 Elsevier, New York.
19. Dhabhar F.S. Acute stress enhances while chronic stress suppresses skin immunity. The role of stress hormones and leukocyte trafficking. Ann. NY Acad. Sci. 917:2000;876-893.
20. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Ader R., Felten D.L., Cohen N., Psychoneuroimmunology. Vol. 2:2001;649-666 Academic Press, New York.
21. Eck J.B., Kuhn C.M. Effect of ether stress on growth hormone during development in the neonatal rat. Neuroendocrinology. 56:1992;605-610.
22. Ely D.R., Dapper V., Marasca J., Correa J.B., Gamaro G.D., Xavier M.H., Michalowski M.B., Catelli D., Rosat R., Ferreira M.B., Dalmaz C. Effect of restraint stress on feeding behavior of rats. Physiol. Behav. 61:1997;395-398.
23. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 1997;Academic Press, San Diego.
24. Furukawa T.A., Streiner D.L., Young L.T. Antidepressant plus benzodiazepine for major depression. Cochrane Database Syst. Rev. 2:2001;. CD001026.
25. Giustina A., Veldhuis J.D. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr. Rev. 19:1998;717-797.
26. Hayley S., Staines W.M., Merali Z., Anisman H. Time-dependent sensitization of corticotropin releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-α Neuroscience. 106:2001;137-148.
27. Hayley S., Brebner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 19:1999;5654-5665.
28. Heinrichs S.C., Koob G.F. Corticotropin-releasing factor modulates dietary preference in nutritionally and physically stressed rats. Psychopharmacology. 109:1992;177-184.
29. Hotta M., Shbasaki T., Yamauchi N., Ohno H., Benoit R., Ling N., Demura H. The effects of chronic central administration of corticotropin-releasing factor on food intake, body weight and HPA hormones. Life Sci. 48:1991;1483-1491.
30. Irwin J., Ahluwalia P., Zacharko R.M., Anisman H. Central norepinephrine and plasma corticosterone following acute and chronic stressors: influence of social isolation and handling. Pharmacol. Biochem. Behav. 24:1986;1151-1154.
31. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 25:2002;154-159.
32. Krahn D.D., Gosnell B.A., Majchrzak M.J. The anorectic effects of CRH and restraint stress decrease with repeated exposures. Biol. Psychiatry. 27:1990;1094-1102.
33. Kuhn C., Schanberg S.M. Responses to maternal separation: mechanisms and mediators. Int. J. Dev. Neurosci. 16:1998;261-270.
34. Kusnecov A., Sved A., Rabin B.S. Immunologic effects of acute versus chronic stress in animals. Ader R., Felten D.L., Cohen N., Psychoneuroimmunology. Vol. 2:2001;265-278 Academic Press, New York.
35. Lacosta S., Merali Z., Anisman H. Influence of interleukin-1 on exploratory behaviors, plasma ACTH and corticosterone, and central biogenic amines in mice. Psychopharmacology. 137:1998;351-361.
36. Lightman S.L., Windle R.J., Julian M.D., Harbuz M.S., Shanks N., Wood S.A., Kershaw Y.M., Ingram C.D. Significance of pulsatility in the HPA axis. Novartis Found. Symp. 227:2000;244-257.
37. Maes M. Major depression and activation of the inflammatory response system. Adv. Exp. Med. Biol. 461:1999;25-46.
38. Maier S.F. Learned helplessness and animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 8:1984;435-446.
39. Marti O., Gavalda A., Jolin T., Armario A. Acute stress attenuates but does not abolish circadian rhythmicity of serum thyrotrophin and growth hormone in the rat. Eur. J. Endocrinol. 136:1996;703-708.
40. Marti O., Marti J., Armario A. Effects of chronic stress on food intake in rats: influence of stressor intensity and duration of daily exposure. Physiol. Behav. 55:1994;747-753.
41. McCann S.M., Kimura M., Karanth S., Yu W.H., Rettori V. Role of nitric oxide in the neuroendocrine responses to cytokines. Ann. NY Acad. Sci. 840:1998;174-184.
42. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 886:2000;172-189.
43. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. NY Acad. Sci. 840:1998;33-44.
44. McEwen B., Brinton R., Chao H., Coirini H., Gannon M.N., Gould E., O'Callaghan J., Spence R., Sakai R.R., Woolley C. The hippocampus: a site for modulatory interaction between steroid hormones, neurotransmitters and neuropeptides. Muller E., Macleod R., Neuroendocrine Perspectives. Vol. 8:1990;93-131 Springer, New York.
45. Meerlo P., Overkamp G.J., Daan S., Van Den Hoofdakker R.H., Koolhaas J.M. Changes in behaviour and body weight following a single or double social defeat in rats. Stress. 1:1996;21-32.
46. Merali Z., Kent P., Anisman H. Role of bombesin-related peptides in the mediation or integration of the stress response. Cell. Mol. Life Sci. 59:2002;272-287.
47. Minami M., Kuraishi Y., Yamaguchi T., Nakai S., Hirai Y., Satoh M. Immobilization stress induces interleukin-1β mRNA in rat hypothalamus. Neurosci. Lett. 123:1991;254-256.
48. Molina V.A., Volosin M., Cancela L., Keller E., Murua V.S., Basso A.M. Effect of chronic variable stress on monoamine receptors: influence of imipramine administration. Pharmacol. Biochem. Behav. 35:1990;335-340.
49. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr. Rev. 5:1984;25-44.
50. Porsolt R.D. Animal models of depression: utility for transgenic research. Rev. Neurosci. 21:2000;53-58.
51. Puglisi-Allegra S., Imperato A., Angelucci L., Cabib S. Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res. 554:1991;217-222.
52. Quartermain D., Stone E.A., Charbonneau G. Acute stress disrupts risk assessment behavior in mice. Physiol. Behav. 59:1996;937-940.
53. Roth R.H., Tam S.Y., Ida Y., Yang J.X., Deutch A.Y. Stress and the mesocorticolimbic dopamine systems. Ann. NY Acad. Sci. 537:1988;138-147.
54. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21:2000;55-89.
55. Seegal R.F., Brosch K.O., Bush B. High performance liquid chromatography of biogenic amines and metabolites in brain, cerebrospinal fluid, urine and plasma. J. Chromatogr. 377:1986;131-144.
56. Shintani F., Nakaki T., Kanba S., Sato K., Kato R., Asai M. Role of interleukin-1 in stress responses. Mol. Neurobiol. 10:1995;47-71.
57. Song C., Merali Z., Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 88:1999;823-836.
58. Stanford S.C. Central noradrenergic neurones and stress. Pharmacol. Ther. 2:1995;297-342.
59. Stone E.A. Central cyclic-AMP-linked noradrenergic receptors: new findings on properties as related to the actions of stress. Neurosci. Biobehav. Rev. 11:1987;391-398.
60. Stout J.C., Weiss J.M. An animal model for measuring behavioral responses to anxiogenic and anxiolytic manipulations. Pharmacol. Biochem. Behav. 47:1994;459-465.
61. Tannenbaum G.S., Martin J.B. Evidence for an endogenous ultradian rhythm governing growth hormone secretion in the rat. Endocrinology. 98:1976;562-570.
62. Terry L.C., Willoughby J.O., Braseau P., Martin J.B., Patel Y. Antiserum to somatostatin prevents stress-induced inhibition of growth hormone secretion in the rat. Science. 192:1976;565-567.
63. Tilders F.J., Schmidt E.D. Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression? Adv. Exp. Med. Biol. 461:1999;179-197.
64. Tilders F.J.H., Schmidt E.D. Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyperresponsiveness. Ann. NY Acad. Sci. 840:1998;65-73.
65. Valles A., Marti O., Garcia A., Armario A. Single exposure to stressors causes long-lasting, stress-dependent reduction of food intake in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279:2000;R1138-1144.
66. Weiss J.M., Simson P.E. Neurochemical and electrophysiological events underlying stress-induced depression in an animal model. Adv. Exp. Med. Biol. 245:1988;425-440.
67. Weiss J.M., Goodman P.A., Losito B.G., Corrigan S., Charry J.M., Bailey W.H. Behavioral depression produced by an uncontrollable stressor: relationship to norepinephrine, dopamine and serotonin levels in various regions of rat brain. Brain Res. Rev. 3:1981;161-191.
68. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology. 134:1997;319-329.
69. Zylan K.D., Brown S.D. Effect of stress and food variety on food intake in male and female rats. Physiol. Behav. 59:1996;165-169.